Microbix Biosystems Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	16.76	18.59	25.39	16.51	19.08	18.59
Revenue Growth (YoY)	-27.22%	-26.81%	53.77%	-13.43%	2.60%	76.66%
Cost of Revenue	8.93	8.73	10	9.03	7.95	7.55
Gross Profit	7.83	9.85	15.39	7.48	11.12	11.04
Selling, General & Admin	9.15	9.1	9.37	8.17	6.72	5.17
Research & Development	2.29	2.33	2.13	2.05	1.8	1.03
Operating Expenses	11.44	11.43	11.49	10.22	8.51	6.21
Operating Income	-3.6	-1.58	3.9	-2.74	2.61	4.84
Interest Expense	-1.02	-0.95	-0.92	-0.84	-0.83	-1.6
Interest & Investment Income	0.35	0.35	0.69	0.46	0.08	0
Currency Exchange Gain (Loss)	-0.06	-0.13	0.01	-	-	-
Other Non Operating Income (Expenses)	-	-	-0	-	-	-
EBT Excluding Unusual Items	-4.33	-2.3	3.67	-3.12	1.87	3.23
Asset Writedown	-	-	-	3.08	-	-
Pretax Income	-4.33	-2.3	3.67	-0.04	1.87	3.23
Income Tax Expense	-0.06	-0.06	0.15	-	0.08	-
Net Income	-4.27	-2.25	3.52	-0.04	1.79	3.23
Net Income to Common	-4.27	-2.25	3.52	-0.04	1.79	3.23
Net Income Growth	-	-	-	-	-44.68%	-
Shares Outstanding (Basic)	140	139	138	138	135	115
Shares Outstanding (Diluted)	140	139	138	138	142	142
Shares Change (YoY)	-0.12%	0.48%	0.42%	-2.67%	0.00%	35.14%
EPS (Basic)	-0.03	-0.02	0.03	-0.00	0.01	0.03
EPS (Diluted)	-0.03	-0.02	0.03	-0.00	0.01	0.03
EPS Growth	-	-	-	-	-49.98%	-
Free Cash Flow	-4.24	-0.88	2.71	-2.11	1.44	0.86
Free Cash Flow Per Share	-0.03	-0.01	0.02	-0.01	0.01	0.01
Gross Margin	46.74%	53.02%	60.61%	45.30%	58.32%	59.40%
Operating Margin	-21.49%	-8.48%	15.35%	-16.57%	13.68%	26.01%
Profit Margin	-25.48%	-12.08%	13.86%	-0.24%	9.38%	17.39%
Free Cash Flow Margin	-25.30%	-4.72%	10.68%	-12.78%	7.55%	4.65%
EBITDA	-2.14	-0.14	5.19	-1.9	3.33	5.39
EBITDA Margin	-12.80%	-0.75%	20.46%	-11.48%	17.45%	28.97%
D&A For EBITDA	1.46	1.44	1.3	0.84	0.72	0.55
EBIT	-3.6	-1.58	3.9	-2.74	2.61	4.84
EBIT Margin	-21.49%	-8.48%	15.35%	-16.57%	13.68%	26.01%
Effective Tax Rate	-	-	4.10%	-	4.14%	-
Revenue as Reported	16.76	18.59	25.39	16.51	19.08	18.59

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.